740 related articles for article (PubMed ID: 29477742)
1. Gastrointestinal colonisation and systemic spread of Candida albicans in mice treated with antibiotics and prednisolone.
Kobayashi-Sakamoto M; Tamai R; Isogai E; Kiyoura Y
Microb Pathog; 2018 Apr; 117():191-199. PubMed ID: 29477742
[TBL] [Abstract][Full Text] [Related]
2. Pathological analysis of the Candida albicans-infected tongue tissues of a murine oral candidiasis model in the early infection stage.
Okada M; Hisajima T; Ishibashi H; Miyasaka T; Abe S; Satoh T
Arch Oral Biol; 2013 Apr; 58(4):444-50. PubMed ID: 23092606
[TBL] [Abstract][Full Text] [Related]
3. [Experimental oral candidiasis in healthy and immunocompromised BALB/c mice].
Karaman M; Kiray M; Bayrakal V; Bağrıyanık HA; Yılmaz O; Bahar IH
Mikrobiyol Bul; 2011 Apr; 45(2):336-43. PubMed ID: 21644077
[TBL] [Abstract][Full Text] [Related]
4. Mucosal damage and neutropenia are required for Candida albicans dissemination.
Koh AY; Köhler JR; Coggshall KT; Van Rooijen N; Pier GB
PLoS Pathog; 2008 Feb; 4(2):e35. PubMed ID: 18282097
[TBL] [Abstract][Full Text] [Related]
5. Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract.
Kadosh D; Najvar LK; Bocanegra R; Olivo M; Kirkpatrick WR; Wiederhold NP; Patterson TF
Antimicrob Agents Chemother; 2016 Nov; 60(11):6703-6708. PubMed ID: 27572393
[TBL] [Abstract][Full Text] [Related]
6. Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection.
Mosci P; Gabrielli E; Luciano E; Perito S; Cassone A; Pericolini E; Vecchiarelli A
Microbes Infect; 2014 Aug; 16(8):678-89. PubMed ID: 24980544
[TBL] [Abstract][Full Text] [Related]
7. Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract.
Vautier S; Drummond RA; Redelinghuys P; Murray GI; MacCallum DM; Brown GD
Infect Immun; 2012 Dec; 80(12):4216-22. PubMed ID: 22988015
[TBL] [Abstract][Full Text] [Related]
8. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice.
Dimitrova P; Ivanovska N
Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122
[TBL] [Abstract][Full Text] [Related]
9. Fatal systemic candidiasis of gastrointestinal origin: an experimental model in mice compromised by anti-cancer treatment.
Sandovsky-Losica H; Barr-Nea L; Segal E
J Med Vet Mycol; 1992; 30(3):219-31. PubMed ID: 1517959
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease.
Kong EF; Kucharíková S; Van Dijck P; Peters BM; Shirtliff ME; Jabra-Rizk MA
Infect Immun; 2015 Feb; 83(2):604-13. PubMed ID: 25422264
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of human saliva on experimental murine oral candidiasis.
Kamagata-Kiyoura Y; Abe S; Yamaguchi H; Nitta T
J Infect Chemother; 2004 Aug; 10(4):253-5. PubMed ID: 15365870
[TBL] [Abstract][Full Text] [Related]
12. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush.
Takakura N; Sato Y; Ishibashi H; Oshima H; Uchida K; Yamaguchi H; Abe S
Microbiol Immunol; 2003; 47(5):321-6. PubMed ID: 12825893
[TBL] [Abstract][Full Text] [Related]
13. A Novel Murine Candidiasis Model with Severe Colonization in the Stomach Induced by N-acetylglucosamine-treatment and Its Scoring System Based on Local Characteristic Stomach Symptoms.
Ishijima SA; Abe S
Med Mycol J; 2015; 56(4):E31-9. PubMed ID: 26617106
[TBL] [Abstract][Full Text] [Related]
14. The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa.
Samaranayake YH; Wu PC; Samaranayake LP; Ho PL
J Med Microbiol; 1998 Dec; 47(12):1047-57. PubMed ID: 9856640
[TBL] [Abstract][Full Text] [Related]
15. Chlamydospore-like cells of Candida albicans in the gastrointestinal tract of infected, immunocompromised mice.
Cole GT; Seshan KR; Phaneuf M; Lynn KT
Can J Microbiol; 1991 Aug; 37(8):637-46. PubMed ID: 1954577
[TBL] [Abstract][Full Text] [Related]
16. Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.
Cutler JE; Corti M; Lambert P; Ferris M; Xin H
PLoS One; 2011; 6(7):e22030. PubMed ID: 21818288
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
[TBL] [Abstract][Full Text] [Related]
18. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans.
Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H
Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610
[TBL] [Abstract][Full Text] [Related]
19. CX3CR1 is dispensable for control of mucosal Candida albicans infections in mice and humans.
Break TJ; Jaeger M; Solis NV; Filler SG; Rodriguez CA; Lim JK; Lee CC; Sobel JD; Netea MG; Lionakis MS
Infect Immun; 2015 Mar; 83(3):958-65. PubMed ID: 25547797
[TBL] [Abstract][Full Text] [Related]
20. N-acetylglucosamine increases symptoms and fungal burden in a murine model of oral candidiasis.
Ishijima SA; Hayama K; Takahashi M; Holmes AR; Cannon RD; Abe S
Med Mycol; 2012 Apr; 50(3):252-8. PubMed ID: 21859389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
